< Back

November/December 2004, Vol. 6, No. 6
Incremental R&D creates safer, more effective drugs & fosters competition
View summary    Purchase single issue

September/October 2004, Vol.6 No.5
Cost issues increasingly drive U.S. formulary and clinical guidelines
View summary    Purchase single issue

July/August 2004, Vol.6 No.4
FDA requested postmarketing studies in 73% of recent new drug approvals
View summary    Purchase single issue

May/June 2004, Vol.6 No.3
Therapeutic class a critical determinant of drug development time & cost
View summary    Purchase single issue

March/April 2004, Vol.6 No.2
Faster review, longer response time mark new EU biopharmaceuticals
View summary    Purchase single issue

January/February 2004, Vol.6 No.1
High cost of drug development spurs new ways to assess and manage risk
View summary    Purchase single issue